Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-062194
Filing Date
2025-06-24
Accepted
2025-06-24 18:39:07
Documents
1
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2518838-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2518838-4_4seq1.xml 4 6720
  Complete submission text file 0001104659-25-062194.txt   8187
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GLYCOMIMETICS, INC. 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address
King Rachel K. (Reporting) CIK: 0001589712 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 251070454